Bayesian Capital Management, LP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 159 filers reported holding CONMED CORP in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$607,218
+28.1%
6,021
+12.6%
0.07%0.0%
Q4 2022$474,135
-23.6%
5,349
-31.0%
0.07%
-45.2%
Q3 2022$621,000
+46.5%
7,749
+43.9%
0.13%
+21.2%
Q3 2020$424,000
-33.6%
5,386
-39.4%
0.10%
-26.2%
Q2 2020$639,000
+28.3%
8,882
+2.1%
0.14%
+30.6%
Q1 2020$498,000
+27.0%
8,702
+148.5%
0.11%
+61.2%
Q4 2019$392,000
+33.8%
3,502
-5.3%
0.07%
+39.6%
Q3 2018$293,000
-4.6%
3,699
-11.9%
0.05%
-30.4%
Q2 2018$307,000
+12.0%
4,199
-32.3%
0.07%
+1.5%
Q4 2016$274,000
+8.7%
6,200
+3.3%
0.07%
-71.3%
Q1 2016$252,0006,0000.24%
Other shareholders
CONMED CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders